Navigation Links
Quinamed in Medical Technology

ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO

MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--Jun 4, 2007 - ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP) announced today the presentation of data from its Quinamed(R) (amonafide dihydrochloride) phase 1/2a dose-escalation study, designed to identify a genotypically optimised...

ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO

-- Genotypically Optimized Dosing Results in Improved Tolerance and Evidence of Anticancer Activity -- MELBOURNE, Australia, and MENLO PARK, California U.S.A. June 04, 2007-ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP) announced today the presentation of data from its Quinamed (amonafide di...
Quinamed in other areas

Quinamed®: ChemGenex Pharmaceuticals

... of Quinamed® used at ... Quinamed® (amonafide dihydrochloride) is a synthetic organic ... In NCI-sponsored clinical studies with amonafide ...

Amonafide Dihydrochloride (Quinamed®): ChemGenex Pharmaceuticals

Clinical trial study of amonafide dihydrochloride (Quinamed®) in the treatment of patients with prostate cancer refractory to hormone therapy and docetaxel at ChemGenex

Quinamed® + ARA-C Effective for Secondary Acute Myeloid Leukemia

... of Quinamed® (amonafide, benzisoquinolinedione, ... Comments: Quinamed may be a very important addition to therapies available for poor-risk AML. ...

Quinamed® + ARA-C Effective for Secondary Acute Myeloid Leukemia

Comments: Quinamed may be a very important addition to therapies available for ... Quinamed® + ARA-C Effective for Secondary Acute Myeloid Leukemia (6/17/2008) ...

Drug Development In Pursuit of Personalized Medicine: ChemGenex ...

... efficacy of the drug, known as Quinamed, by calibrating the dose to a prostate ... two drugs in clinical trials, Quinamed and Cleflatonin, a drug in phase ...

Genotypically Optimized Dosing Results In Improved Tolerance And ...

ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP) has announced the presentation of data from its Quinamed® (amonafide dihydrochloride) phase 1/2a dose-escalation ...
Other Tags
(Date:7/4/2015)... (PRWEB) , ... July 04, 2015 , ... ... the solar industry’s leading recognition of technical sales expertise from the North American ... Technical Sales ProfessionalTM. NABCEP is the most highly respected and well established national ...
(Date:7/3/2015)... ... 03, 2015 , ... On June 30th SEO authority and ... system called "Page One Engine" . The program, which has been hailed ... from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined the party, publishing an ...
(Date:7/3/2015)... ... 2015 , ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. ... Symposium . To be held from March 4th - 6th, the 2016 (a previous ... Galleria Dallas. , Designed to take participants from the basic training and fundamentals of ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... took place on June 25, 2015 at 1:00pm. The Association welcomed speaker C. ... pertaining to injured bicyclists and practical points of investigating these types of cases. ...
(Date:7/3/2015)... ... July 03, 2015 , ... Jennifer Renee Hanes, DO is the ... , the largest network of independent freestanding emergency rooms in the United States. , ... our Sienna Plantation facility,” said Executive Medical Director of First Choice Emergency Room, Dr. ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3
(Date:6/29/2015)... 2015 Research and Markets( ... "Latin America Biomedical Sensors Market - Growth, Trends & ... The Latin America Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
(Date:6/25/2015)... June 25, 2015 According ... Type (Swipe & Area), Technology, Material (Optical Prism, ... Commercial Security & Others) & Geography - Global ... the said market is expected to reach $14,500.07 ... Browse 76 market Tables and ...
(Date:6/25/2015)... , June 25, 2015  TAKE Solutions Ltd., a ... by the United States Patent and Trademark Office (USPTO) ... process leverages TAKE Solutions, Clinical Accelerators to reduce the ... (when compared to standardization without the accelerators), thus reducing ... At the heart of the patented ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4TAKE Solutions Awarded Patent By USPTO 2
Other Contents